Holen Sie sich die Stockscreener-App
118.08
2.28%
-2.61
Schlusskurs vom Vortag:
$120.69
Offen:
$119.96
24-Stunden-Volumen:
118.28K
Relative Volume:
0.15
Marktkapitalisierung:
$6.64B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-380.90
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
-0.79%
1M Leistung:
-0.82%
6M Leistung:
-24.10%
1J Leistung:
-16.82%
1-Tages-Spanne:
$117.75
$121.71
1-Wochen-Bereich:
$117.61
$124.91
52-Wochen-Spanne:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
118.05 | 6.88B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
449.45 | 169.67B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.16 | 55.31B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
78.27 | 39.46B | 10.03B | 1.07B | 1.39B | 2.17 |
|
RMD
Resmed Inc
|
265.98 | 40.19B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
243.39 | 17.76B | 2.96B | 487.70M | 344.00M | 6.68 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
What recovery options are there for Repligen CorporationJuly 2025 Breakouts & Reliable Price Breakout Alerts - Newser
Custom watchlist performance reports with Repligen CorporationJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Risk adjusted return profile for Repligen Corporation analyzed2025 Price Action Summary & Community Driven Trade Alerts - Newser
Repligen Corporation stock daily chart insights2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
Why Repligen Corporation is moving todayJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Should you wait for a breakout in Repligen Corporation2025 EndofYear Setup & Community Consensus Stock Picks - Newser
Repligen appoints Violetta Hughes as chief accounting officer effective September 1 - Investing.com
Statistical indicators supporting Repligen Corporation’s strengthJuly 2025 Recap & Community Verified Trade Signals - Newser
What’s the outlook for Repligen Corporation’s sectorWeekly Trading Summary & Intraday High Probability Setup Alerts - khodrobank.com
What the charts say about Repligen Corporation todayPortfolio Risk Report & Entry Point Confirmation Alerts - Newser
What are Repligen Corporation’s earnings expectations2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - khodrobank.com
Is Repligen Corporation building a consolidation baseSell Signal & Verified Stock Trade Ideas - Newser
Will Repligen Corporation price bounce be sustainableLayoff News & Weekly Top Stock Performers List - Newser
How to monitor Repligen Corporation with trend dashboards2025 Pullback Review & Expert Approved Momentum Ideas - Newser
Using RSI to spot recovery in Repligen CorporationWeekly Stock Recap & High Return Stock Watch Alerts - Newser
Can Repligen Corporation maintain its current growth rate2025 Institutional Moves & Safe Capital Growth Trade Ideas - khodrobank.com
Will Repligen Corporation benefit from macro trendsJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Institutional scanner results for Repligen CorporationJuly 2025 Action & Weekly Top Stock Performers List - Newser
Strategies to average down on Repligen CorporationEarnings Recap Summary & Daily Stock Trend Watchlist - Newser
Applying Elliott Wave Theory to Repligen Corporation2025 Major Catalysts & Fast Entry and Exit Trade Plans - Newser
How Repligen Corporation stock performs during market volatility2025 Market Overview & Free Weekly Chart Analysis and Trade Guides - Newser
Evaluating Repligen Corporation with trendline analysisTrade Analysis Report & Growth Oriented Trade Recommendations - Newser
Analyzing recovery setups for Repligen Corporation investorsJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
What’s next for Repligen Corporation stock price2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Using fundamentals and technicals on Repligen Corporation2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Visual trend scoring systems applied to Repligen CorporationBreakout Watch & Free Growth Oriented Trading Recommendations - Newser
Long term hold vs stop loss in Repligen CorporationJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Building trade automation scripts for Repligen CorporationWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Has Repligen Corporation found a price floor2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
Repligen Corporation stock momentum explainedJuly 2025 PreEarnings & Intraday High Probability Setup Alerts - Newser
Understanding Repligen Corporation’s price movement2025 Retail Activity & Safe Entry Zone Identification - Newser
Repligen Corporation stock prediction for this weekMarket Sentiment Report & Daily Momentum Trading Reports - Newser
Does Repligen Corporation fit your quant trading model2025 Buyback Activity & Weekly Stock Breakout Alerts - Newser
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):